FDA Approved: OTEZLA — Original Application (Amgen, Inc)

View source ↗

Summary

FDA approved OTEZLA (apremilast) from Amgen in its Original Application for the treatment of plaque psoriasis and psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

ORIG AP for OTEZLA (APREMILAST)